Xinkui Liu

ORCID: 0000-0002-8457-3003
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Clinical practice guidelines implementation
  • Global Cancer Incidence and Screening
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Economic and Financial Impacts of Cancer
  • Long-Term Effects of COVID-19
  • Lung Cancer Treatments and Mutations
  • Cancer Mechanisms and Therapy
  • Cancer Research and Treatments
  • Cardiovascular Function and Risk Factors
  • Genomics, phytochemicals, and oxidative stress
  • PI3K/AKT/mTOR signaling in cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer, Lipids, and Metabolism
  • Lung Cancer Research Studies
  • Cardiac Ischemia and Reperfusion
  • Fuel Cells and Related Materials
  • Ferroptosis and cancer prognosis

First Affiliated Hospital of Zhengzhou University
2011-2021

Zunyi Medical University
2015

Coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China, December 2019. Although previous studies have described the clinical aspects of COVID-19, few focused on early detection severe COVID-19. Therefore, this study aimed to identify predictors COVID-19 and compare features between patients with those less Patients admitted designated hospital Henan Province China who were either discharged or died prior February 15, 2020 enrolled retrospectively. Additionally, underwent at...

10.1371/journal.pone.0235459 article EN cc-by PLoS ONE 2020-06-26

Objective: To analyze the changes of bronchoalveolar lavage fluid (BALF) and serum tumor markers in lung cancer. Materials Methods: Fifty patients with cancer (study group) 50 cases benign lesions (control were selected from May, 2010 to 2013. The observation group included squamous cell carcinoma subgroup (n = 25), adenocarcinoma 19), small undifferentiated 6). carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), cytokeratin 19 fragment (CYFRA21-1) concentration compared;...

10.4103/0973-1482.162111 article EN Journal of Cancer Research and Therapeutics 2016-01-01

Abstract Background To evaluate the performance of medical service for patients with breast cancer in Henan Province, China, using diagnosis related groups (DRGs) indicators and to provide data inform practices policies prevention control cancer. Methods The were collected from front pages records (FPMR) all hospitals above class II that admitted Province between 2016 2019. Breast subjects our study. China DRGs (CN-DRGs) was used as a risk adjustment tool. Three indicators, including case...

10.1186/s12913-021-06439-8 article EN cc-by BMC Health Services Research 2021-05-24

Mitochondrial ATP-sensitive potassium channel (mito<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mrow><mml:msub><mml:mrow><mml:mtext>K</mml:mtext></mml:mrow><mml:mrow><mml:mtext>ATP</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>) is a common end effector of many protective stimuli in myocardial ischemia-reperfusion injury (MIRI). However, the specific molecular mechanism underlying its effect not well elucidated. We characterized an anoxia/reoxygenation (A/R)...

10.1155/2015/756576 article EN cc-by Oxidative Medicine and Cellular Longevity 2015-01-01

Abstract Background: To evaluate health system performance for patients with breast cancer in Henan Province, China, using Diagnosis-Related Groups (DRGs) indicators and provide data to inform practices policies the prevention control of cancer. Methods: The were collected from front pages medical records (FPMR) all hospitals above class II that admitted Province between 2016 2019. Breast subjects our study. China DRGs (CN-DRGs) used as a risk adjustment tool. Three indicators, including...

10.21203/rs.3.rs-20222/v1 preprint EN cc-by Research Square (Research Square) 2020-04-21

The Coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China during December of 2019. Previous studies have described clinical aspectsof the COVID-19 illness;however, insufficient literature currently exists regarding detecting severe conditions patients early diagnosisstage. Patients admitted to a designated hospital Henan Province with outcomes either discharge or death before February 15, 2020 were enrolled retrospectively as cohort study population. who underwent at least...

10.17504/protocols.io.bfpejmje preprint EN 2020-04-28

Abstract Background: To evaluate health system performance for patients with breast cancer in Henan Province, China, using Diagnosis-Related Groups (DRGs) indicators and provide data to inform practices policies the prevention control of cancer. Methods: The were collected from front pages medical records (FPMR) all hospitals above class II that admitted Province between 2016 2019. Breast subjects our study. China DRGs (CN-DRGs) used as a risk adjustment tool. Three indicators, including...

10.21203/rs.3.rs-20222/v2 preprint EN cc-by Research Square (Research Square) 2020-10-28
Coming Soon ...